Mutation signatures implicate aristolochic acid in bladder cancer development
about
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations.Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro ScreeningSomatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.Somatic mutation in cancer and normal cells.Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.Exploring background mutational processes to decipher cancer genetic heterogeneity.Aristolochic Acid in the Etiology of Renal Cell Carcinoma.Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.Computational approaches for discovery of mutational signatures in cancer.A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.DNA methylation in urothelial carcinoma.Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair
P2860
Q30249783-28A5F61B-7DC1-46D5-89D5-33D7A3DF5954Q35996745-C3AFB4AF-E194-40D0-BE6D-40BFB780F929Q36013147-4753C2FC-E458-460E-9323-6DE33429E4E1Q36725046-ED2B3FD4-E8C2-4D85-A19C-0FD1938CFE71Q36743729-4FA8AB8F-F40F-4D04-8EEA-23DBC7BB4476Q37074346-678A1FFB-0E95-429A-A3CF-42C74780BFAAQ38592662-5315DFC6-181C-4A9B-86EB-175852743797Q38652450-D58718E2-AB92-45F5-BA1B-D42ECEE63D8CQ38803947-78132246-276F-4A9D-B1F2-5027C8C7EB0BQ39459925-51263E76-5D4A-4BE5-BBDE-80525E691C98Q47431964-D641F828-A9EB-497A-867E-4395EC063287Q47664589-EED59921-8A8E-4F31-BA3D-9F25ED700D9DQ49723795-61FF9F61-E723-4871-AF1C-EA6F8574A25AQ49725884-3554687A-F4D4-4EB9-A0D9-5B19DCA82F81Q52646970-56A075A9-7A9C-4A5A-B65B-165FC2281CB3Q53691833-A8558966-87EB-4242-9A40-3F95ED976CDBQ58701171-6D531EB4-FB3D-462A-8E66-05299126F2C7
P2860
Mutation signatures implicate aristolochic acid in bladder cancer development
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mutation signatures implicate aristolochic acid in bladder cancer development
@ast
Mutation signatures implicate aristolochic acid in bladder cancer development
@en
type
label
Mutation signatures implicate aristolochic acid in bladder cancer development
@ast
Mutation signatures implicate aristolochic acid in bladder cancer development
@en
prefLabel
Mutation signatures implicate aristolochic acid in bladder cancer development
@ast
Mutation signatures implicate aristolochic acid in bladder cancer development
@en
P2093
P2860
P1433
P1476
Mutation signatures implicate aristolochic acid in bladder cancer development
@en
P2093
Cheng-Keng Chuang
Ee Yan Siew
Hong Lee Heng
John R McPherson
John Sp Yuen
Lay Guat Ng
Lian Dee Ler
Mi Ni Huang
Patrick Tan
P2860
P2888
P356
10.1186/S13073-015-0161-3
P50
P577
2015-04-28T00:00:00Z
P5875
P6179
1029134559